Insmed (INSM) Other Accumulated Expenses (2011 - 2026)

Insmed's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $23.3 million for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 112.86% year-over-year to $23.3 million in Q1 2026; TTM through Mar 2026 was $23.3 million, a 112.86% increase from a year earlier, with the FY2025 full-year figure at $17.1 million, up 170.41% from the prior year.
• Other Accumulated Expenses rose to $23.3 million in Q1 2026 per INSM's latest filing, from $17.1 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $23.3 million in Q1 2026 and bottomed at $1.8 million in Q1 2023.
• The 5-year median for Other Accumulated Expenses is $6.5 million (2024), against an average of $8.2 million.
• Across the five-year window, Other Accumulated Expenses declined 29.23% in 2022 and surged 262.75% in 2024, its largest moves.
• Year by year, Other Accumulated Expenses stood at $4.7 million in 2022, then gained by 20.47% to $5.7 million in 2023, then gained by 11.46% to $6.3 million in 2024, then jumped by 170.41% to $17.1 million in 2025, then soared by 36.19% to $23.3 million in 2026.
• Per Business Quant, the three latest INSM Other Accumulated Expenses figures stand at $23.3 million (Q1 2026), $17.1 million (Q4 2025), and $9.4 million (Q3 2025).